Diabetes-induced vascular dysfunction involves arginase I
about
Targeting Nitric Oxide with Natural Derived Compounds as a Therapeutic Strategy in Vascular DiseasesRole for high-glucose-induced protein O-GlcNAcylation in stimulating cardiac fibroblast collagen synthesisVitamin D is a regulator of endothelial nitric oxide synthase and arterial stiffness in miceEffect of medicinal mushrooms on blood cells under conditions of diabetes mellitusNovel therapeutic strategies for adult obese asthmatics.Rho/Rho-associated coiled-coil forming kinase pathway as therapeutic targets for statins in atherosclerosis.Arginase 2 deficiency prevents oxidative stress and limits hyperoxia-induced retinal vascular degeneration.The role of arginase I in diabetes-induced retinal vascular dysfunction in mouse and rat models of diabetes.New approaches to the design and discovery of therapies to prevent erectile dysfunction.Arginase in retinopathy.Akita spontaneously type 1 diabetic mice exhibit elevated vascular arginase and impaired vascular endothelial and nitrergic function.Requirement of NOX2 expression in both retina and bone marrow for diabetes-induced retinal vascular injury.Role of hydrogen sulfide in skeletal muscle biology and metabolism.Angiotensin II-induced arterial thickening, fibrosis and stiffening involves elevated arginase functionComparison of the effect of topical versus systemic L-arginine on wound healing in acute incisional diabetic rat model.Tissue-specific up-regulation of arginase I and II induced by p38 MAPK mediates endothelial dysfunction in type 1 diabetes mellitus.Deregulation of arginase induces bone complications in high-fat/high-sucrose diet diabetic mouse modelPrevention of diabetes-induced arginase activation and vascular dysfunction by Rho kinase (ROCK) knockout.Arginase promotes skeletal muscle arteriolar endothelial dysfunction in diabetic ratsVasomotor regulation of coronary microcirculation by oxidative stress: role of arginase.Insights into the arginine paradox: evidence against the importance of subcellular location of arginase and eNOS.l-Citrulline Protects from Kidney Damage in Type 1 Diabetic Mice.Arginase 2 promotes neurovascular degeneration during ischemia/reperfusion injury.Arginase 2 deficiency reduces hyperoxia-mediated retinal neurodegeneration through the regulation of polyamine metabolism.Arginase as a potential target in the treatment of cardiovascular disease: reversal of arginine steal?RhoA/mDia-1/profilin-1 signaling targets microvascular endothelial dysfunction in diabetic retinopathy.Arginase: an old enzyme with new tricks.Endothelial dysfunction and vascular disease - a 30th anniversary update.Arginase Inhibitors: A Rational Approach Over One Century.Arginase as a mediator of diabetic retinopathy.Effects of the Hydroalcoholic Extract of Zingiber officinale on Arginase I Activity and Expression in the Retina of Streptozotocin-Induced Diabetic Rats.The subcellular compartmentalization of arginine metabolizing enzymes and their role in endothelial dysfunction.Obesity-induced vascular dysfunction and arterial stiffening requires endothelial cell arginase 1.Differential expression of genes identified by suppression subtractive hybridization in liver and adipose tissue of gerbils with diabetes.Mechanisms of Diabetes-Induced Endothelial Cell Senescence: Role of Arginase 1.Deletion of endothelial arginase 1 does not improve vasomotor function in diabetic mice.single nucleotide polymorphisms rs2781666 and rs2781665 confer risk of Type 2 diabetes mellitus
P2860
Q28073279-3655D5B0-2EC5-4E65-93FA-7050658EC0F7Q33569387-7F17C956-C090-46C8-B24C-23A51574B502Q33663682-E33E8FB6-EC7A-4487-8897-9010B7AAAEA9Q33706752-CF3E0163-F508-468A-AFFC-D04F07262593Q34290008-81D74F43-2E50-4019-B5F7-998FE23A90A1Q34362144-ABD90202-DE75-431E-8CC7-94D83910B526Q34465434-8D7B72CA-0FFB-43BC-928E-1035B9CB69B2Q34509144-B6D5FC69-3287-4F33-A8E2-F61D88AECF04Q34664336-CC053144-0C9C-40AC-8E5C-D933F15DBE69Q34800913-34756862-E6AE-4BA9-AC31-3C80964A580DQ34973749-AD557171-8E39-4CF8-A63D-CF8A9A6F1805Q35073329-A42B342C-A636-4DD8-A61F-349CC28FF87FQ35181112-4A70D07B-7F0E-429C-8AA3-0B5C76C93E97Q35217395-50228133-D2E2-43FB-A6FF-B508D7309353Q35744798-33A8B267-048F-44A2-852E-B1A360002878Q36124220-E9D71F4F-0D8B-46DD-9FF7-C511B472469FQ36775423-E173F605-16B0-4F00-B1B5-24CDEEC42AE6Q36787307-D4F55EC7-4EE4-417E-AA1F-BA915F308FEBQ36854784-5F225EE1-1060-4B6B-A74F-75D0E40CFBD7Q37102697-90370625-0CBC-48B5-A92D-2B3DB7CB8533Q37142734-6D9441E4-8888-4C77-8B9D-EAE2B4C28EB0Q37412089-666BD0C4-6AC6-47D0-B265-32AE40153129Q37603245-4604FE4F-06BD-4CA6-A168-C6C65096E176Q37620647-9ECC6B25-3F42-4BA4-A1DB-0E1EFBF7867EQ38082329-0F1645F1-5A6B-4846-8699-5CC53532E949Q38384340-8AE39A65-DA57-40AB-B447-91212B899080Q38452432-30C509BE-495A-4835-BE5E-80E834BF5074Q38680112-D1CEFE9A-8855-4CFA-B465-3DCBDB980D2FQ39012928-E4D77A18-C350-4053-8F93-428358EE8149Q41285088-341220AA-F366-4B84-B426-4E7E7745E8AFQ41384119-F63701C4-9FE5-4678-9607-738BD9B4EC57Q43101543-E340651A-0E4F-4F47-BEFF-52C3E6250C7FQ47734746-52882DAE-EC1A-4DEA-B7FF-7563CEFF2BAAQ48114214-2ACA9D91-C723-46C7-B7BF-08882959E435Q55153776-F1E28A3B-4226-43AC-935D-572C440D9CB9Q55242323-E3FDF5BE-CC6E-4F79-979E-098DCEDED864Q58700252-B1DBEA63-6B46-496A-8633-9D96DC520D67
P2860
Diabetes-induced vascular dysfunction involves arginase I
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Diabetes-induced vascular dysfunction involves arginase I
@ast
Diabetes-induced vascular dysfunction involves arginase I
@en
type
label
Diabetes-induced vascular dysfunction involves arginase I
@ast
Diabetes-induced vascular dysfunction involves arginase I
@en
prefLabel
Diabetes-induced vascular dysfunction involves arginase I
@ast
Diabetes-induced vascular dysfunction involves arginase I
@en
P2093
P2860
P1476
Diabetes-induced vascular dysfunction involves arginase I
@en
P2093
Daniel H Platt
David W Stepp
Jennifer A Iddings
M Irfan Ali
Maritza J Romero
Robert W Caldwell
Ruth B Caldwell
Stephen D Cederbaum
P2860
P304
P356
10.1152/AJPHEART.00774.2011
P577
2011-11-04T00:00:00Z